Debiopharm Group™ has developed extensive skills in the field of drug development, successfully bringing new drugs to market.
Debiopharm Group's development activities also cover the following areas:
- Applied research in the field of peptides, e.g. redesign of molecules to enhance their safety and/or efficacy profile
- Drug delivery research, for instance to facilitate the administration of drugs to patients in emerging markets for whom a daily pill or a daily injection may not be practical
- Life-cycle management from a relatively early stage
- Industrial manufacturing involving the company’s own proprietary technology. Debio R.P, located in Martigny (Valais, Switzerland) has FDA and SwissMedic manufacturing facilities
- Companion diagnostics, with a view to progressing in the area of personalized medicine
